Loading...

APC/Cyanine7 anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_APCCyanine7_F4-80_Antibody_020119
Thioglycolate-elicited Balb/c mouse peritoneal macrophages were stained with CD11b FITC and F4/80 (clone BM8) APC/Cyanine7 (left) or Rat IgG2a, ? APC/Cyanine7 isotype control (right).
  • BM8_APCCyanine7_F4-80_Antibody_020119
    Thioglycolate-elicited Balb/c mouse peritoneal macrophages were stained with CD11b FITC and F4/80 (clone BM8) APC/Cyanine7 (left) or Rat IgG2a, ? APC/Cyanine7 isotype control (right).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Save
123117 25 µg ¥30,360
123118 100 µg ¥71,500
Description

F4/80, also known as EMR1 or Ly71, is a 160 kD glycoprotein of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80 has been widely used as a murine macrophage marker. It is expressed on a majority of tissue macrophages, including macrophages in the lung, gut, peritoneal cavity, thymus, and red pulp of the spleen, Kupffer cells, Langerhans cells, microglia, and certain dendritic cells. It is not expressed on macrophages located in the T cell areas of the spleen, lymph node, or Peyer's patch. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for the induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 1.0 µg per 106 cells in 100 µl. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Additional Product Notes
BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  2. Grandjean CL, et al. 2021. Sci Adv. 7:. PubMed
  3. Bruand M, et al. 2021. Cell Reports. 36(3):109412. PubMed
  4. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  5. Resende M, et al. 2017. J Immunol. 10.4049/jimmunol.1601701. PubMed
  6. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  7. Pilch Z, et al. 2018. Cancer Immunol Res. 6:930. PubMed
  8. Marques RM, et al. 2021. Cell Death Differ. 28:3140. PubMed
  9. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  10. Kozijn AE, et al. 2019. Osteoarthritis Cartilage. 27:118. PubMed
  11. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  12. Diao L, et al. 2022. iScience. 25:105511. PubMed
  13. Nawaz A, et al. 2022. Nat Commun. 13:7058. PubMed
  14. Andreas N, et al. 2021. Arthritis Res Ther. 23:222. PubMed
  15. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  16. Vicario N, et al. 2021. Cell Death Disease. 12(7):625. PubMed
  17. Culina S, et al. 2014. PLoS One. 9:88365. PubMed
  18. Ushio A, et al. 2017. Int J Mol Sci. 10.3390/ijms18061209. PubMed
  19. Wang X, et al. 2020. Signal Transduct Target Ther. 5:35. PubMed
  20. Bode K, et al. 2020. Cell Reports. 29(13):4435-4446.e9.. PubMed
  21. Nguyen SL, et al. 2021. Sci Rep. 11:4217. PubMed
  22. Li S, et al. 2021. Ann Transl Med. 9:1644. PubMed
  23. Dias AMM, et al. 2021. J Gastroenterol. 56:442. PubMed
  24. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  25. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  26. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  27. Han YH, et al. 2021. Science. 373:. PubMed
  28. Forni MF, et al. 2021. Front Oncol. 11:667715. PubMed
  29. Chen C, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.02.040. PubMed
  30. Herbst S, et al. 2013. Dis Model Mech. 6:643. PubMed
  31. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  32. Brykczynska U, et al. 2020. Cell Reports. 30(5):1627-1643.e7.. PubMed
  33. Ohta S, et al. 2013. J Immunol. 190:5927. PubMed
  34. Mason K, et al. 2013. J Immunol. 191:2457. PubMed
  35. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  36. Li J, et al. 2020. Cancer Discov. . PubMed
  37. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  38. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  39. Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
  40. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  41. Peruzzotti-Jametti L, et al. 2021. PLoS Biol. 19:e3001166. PubMed
  42. Li J, et al. 2020. Cancer Immunol Res. 0.529166667. PubMed
  43. Taguchi K, et al. 2015. J Urol. . PubMed
  44. Li J, et al. 2018. Immunity. 49:178. PubMed
  45. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  46. Gao S, et al. 2022. Cell Res. 32:38. PubMed
  47. Pitsch J, et al. 2021. Ann Neurol. 89:666. PubMed
  48. Taguchi K, et al. 2014. J Am Soc Nephrol. 25:1680. PubMed
  49. Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
  50. Watanabe E, et al. 2020. Angiogenesis. 23(4):667-684. PubMed
  51. Haloul M, et al. 2019. Sci Rep. 9:14050. PubMed
  52. Guo M, et al. 2018. J Immunol. 200:1039. PubMed
  53. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  54. Yang M, et al. 2021. Cancer Immunol Immunother. 70:2467. PubMed
  55. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  56. Xue N, et al. 2017. Sci Rep. 7:39011. PubMed
  57. Pilch Z, et al. 2019. PLoS One. 14:e0210796. PubMed
  58. Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed
  59. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  60. Bugler-Lamb AR, et al. 2021. Mol Metab. 49:101197. PubMed
  61. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  62. Bourque J, et al. 2021. Heliyon. 7:e08311. PubMed
  63. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  64. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  65. De Simone G, et al. 2021. Immunity. :. PubMed
  66. Blriot C, et al. 2021. Immunity. :. PubMed
  67. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  68. Zordan P, et al. 2013. Eur J Pharmacol. 715:296. PubMed
  69. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  70. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  71. Kolodkin-Gal D, et al. 2021. Gut. Online ahead of print. PubMed
  72. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  73. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  74. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  75. Bagadia P, et al. 2019. Nat Immunol. 20:1174. PubMed
  76. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  77. Dichtl S, et al. 2022. Life Sci Alliance. 5:. PubMed
  78. Moro T, et al. 2016. PLoS One. 11: 0146592. PubMed
  79. Natale CA, et al. 2018. Elife. 7. PubMed
  80. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  81. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  82. de Assis LVM, et al. 2022. Commun Biol. 5:461. PubMed
  83. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  84. Ni Y, et al. 2021. Theranostics. 11:9431. PubMed
  85. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  86. Bergquist M, et al. 2014. J Infect. 69:113. PubMed
  87. Peruzzotti-Jametti L, et al. 2018. Cell Stem Cell. 22:355. PubMed
  88. Leiria LO et al. 2019. Cell Metab. 30(4):768-783 . PubMed
  89. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  90. Zhang Z, et al. 2020. Front Immunol. 11:583276. PubMed
  91. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  92. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  93. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  94. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  95. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  96. Celià-Terrassa T, et al. 2017. Nat Cell Biol. 19:711. PubMed
  97. Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
  98. Wang M, et al. 2021. iScience. 24(7):102766. PubMed
  99. Kwok I, et al. 2020. Immunity. 53(2):303-318.e5. PubMed
  100. DeFalco T, et al. 2016. Cell Rep. 12: 1107-1119. PubMed
  101. Bertuzzi M, et al. 2014. PLoS Pathog. 10:1004413. PubMed
  102. Mellal K, et al. 2019. Sci Rep. 9:12903. PubMed
  103. Herbst S, et al. 2015. EMBO Mol Med. 30:240. PubMed
  104. Cardoso M, et al. 2015. Infect Immun . 83: 3534-3544. PubMed
  105. Chen Z, et al. 2016. Innate Immunity. 22: 419 - 432. PubMed
  106. Kahn JH, et al. 2020. Endocrinology. 161(10):. PubMed
  107. Morrissey MA, et al. 2018. Elife. 7:e36688. PubMed
  108. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  109. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  110. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
  111. Ren X, et al. 2021. Cell Death Dis. 12:484. PubMed
  112. Sameshima A, et al. 2015. J Endocrinol. 227: 25-36. PubMed
RRID
AB_893489 (BioLegend Cat. No. 123117)
AB_893477 (BioLegend Cat. No. 123118)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kupffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
UniProt
View information about F4/80 on UniProt.org
Go To Top Version: 3    Revision Date: 02/01/2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account